← Back to Search

Software System

SMART-Wrap for Mental Health Services (SMART-Wrap Trial)

N/A
Recruiting
Led By Melissa DeRosier, PhD
Research Sponsored by 3-C Institute for Social Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45-minutes, completed after the test of the smart-wrap system
Awards & highlights

SMART-Wrap Trial Summary

This trial tests a system to help with mental health issues in youth. It will be cost-efficient and scalable, helping meet the need for better mental health care.

SMART-Wrap Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45-minutes, completed after the test of the smart-wrap system
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45-minutes, completed after the test of the smart-wrap system for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prototype Evaluation for Care Team Members
Prototype Evaluation for Families
System Usability Survey
Secondary outcome measures
Results from Caregiver Text Message Items
Results from Youth Text Message Items
Results from focus groups / interviews with care team members
+3 more

SMART-Wrap Trial Design

1Treatment groups
Experimental Treatment
Group I: SMART-WrapExperimental Treatment1 Intervention
SMART-Wrap is a prototype measurement and feedback software system tailored to Wraparound service model (WSM) for emotional disorders to provide measurement-based care in care coordination for youth behavioral health.

Find a Location

Who is running the clinical trial?

3-C Institute for Social DevelopmentLead Sponsor
12 Previous Clinical Trials
2,067 Total Patients Enrolled
University of WashingtonOTHER
1,749 Previous Clinical Trials
1,838,549 Total Patients Enrolled
1 Trials studying Mental Health Services
1,520 Patients Enrolled for Mental Health Services
Melissa DeRosier, PhDPrincipal Investigator3C Institute
1 Previous Clinical Trials
57 Total Patients Enrolled
~42 spots leftby May 2025